comparemela.com
Latest Breaking News On - New indication expected - Page 1 : comparemela.com
FDA Approves Medicines360's Supplemental New Drug Application for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg as Treatment of Heavy Menstrual Bleeding
/PRNewswire/ – Medicines360, a global nonprofit organization with a mission to catalyze equitable access to quality medicines for women, announced today that.
California
United-states
San-francisco
Andrea-olariu
Drug-administration
B-drug-pricing-program
New-indication-expected
Increase-treatment-options
Heavy-menstrual-bleeding
New-drug-application
Heavy-menstrual
Drug-pricing
vimarsana © 2020. All Rights Reserved.